Home › Funds › Parametrica Management Ltd › IPSC
Parametrica Management Ltd position in IPSC
CENTURY THERAPEUTICS INC · Health Care
Parametrica Management Ltd reported holding 27,840 shares of IPSC (CENTURY THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$48K, representing 0.04% of its reported portfolio and ranking #25 among its reported holdings. Parametrica Management Ltd has disclosed IPSC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Parametrica Management Ltd's IPSC position evolved
Parametrica Management Ltd first disclosed a stake in IPSC in Q3 2023 at 27,840 shares (US$56K). The position peaked in Q1 2024 at 27,840 shares, worth US$116K. Across 13 filings, Parametrica Management Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 27,840 shares valued at US$48K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 27.84K | $55.68K | New |
| Q4 2023 | 27.84K | $92.43K | Hold |
| Q1 2024 | 27.84K | $116.37K | Hold |
| Q2 2024 | 27.84K | $70.99K | Hold |
| Q3 2024 | 27.84K | $47.61K | Hold |
| Q4 2024 | 27.84K | $28.12K | Hold |
| Q1 2025 | 27.84K | $13.25K | Hold |
| Q2 2025 | 27.84K | $15.55K | Hold |
| Q3 2025 | 27.84K | $13.86K | Hold |
| Q4 2025 | 27.84K | $27.70K | Hold |
| Q1 2026 | 27.84K | $62.92K | Hold |
| Q2 2026 | 27.84K | $68.21K | Hold |
| Q3 2026 | 27.84K | $47.61K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IPSC and 13F data
IPSC (CENTURY THERAPEUTICS INC) is a Health Care company. 50 other funds we track also report a position in IPSC — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$43.5M), TCG Crossover Management, LLC (US$43.4M), Versant Venture Management, LLC (US$29.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IPSC
- RA CAPITAL MANAGEMENT, L.P. 17.75M sh · $43.50M · Q2 2026
- TCG Crossover Management, LLC 17.75M sh · $43.40M · Q2 2026
- Versant Venture Management, LLC 12.17M sh · $29.81M · Q2 2026
- Commodore Capital LP 8.70M sh · $21.30M · Q2 2026
- Venrock Adviser, LLC 8.70M sh · $21.30M · Q2 2026
- Seven Fleet Capital Management LP 4.35M sh · $10.65M · Q2 2026
- Trails Edge Capital Partners, LP 4.13M sh · $10.13M · Q2 2026
- Spruce Street Capital LP 4.06M sh · $9.94M · Q2 2026
- DAFNA Capital Management LLC 2.40M sh · $5.88M · Q2 2026
- STEMPOINT CAPITAL LP 2.15M sh · $5.26M · Q2 2026
- DV Trading LLC 1.40M sh · $3.43M · Q2 2026
- Casdin Capital 1.23M sh · $3.01M · Q2 2026
More on Parametrica Management Ltd
FAQ
How long has Parametrica Management Ltd held IPSC?
Parametrica Management Ltd has disclosed IPSC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parametrica Management Ltd's current position in IPSC?
As of Q3 2026, Parametrica Management Ltd holds 27.84K shares of IPSC (CENTURY THERAPEUTICS INC), valued at $47.61K, representing 0.04% of its reported portfolio and ranking #25.
Has Parametrica Management Ltd been buying or selling IPSC?
In the latest 13F filing (Q3 2026), Parametrica Management Ltd held unchanged its position in IPSC. The position peaked in Q1 2024 at 27.84K shares.
Which other funds hold IPSC?
Other major institutional holders of IPSC include RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, Versant Venture Management, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.